financetom
Business
financetom
/
Business
/
Zillow Q4 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zillow Q4 Adjusted Earnings, Revenue Rise
Mar 11, 2026 3:37 AM

04:23 PM EST, 02/10/2026 (MT Newswires) -- Zillow ( ZG ) (Z, ZG) reported Q4 adjusted earnings late Tuesday of $0.39 per diluted share, up from $0.27 a year earlier.

Analysts polled by FactSet expected $0.40.

Revenue for the three months ended Dec. 31 was $654 million, up from $554 million a year earlier.

Analysts surveyed by FactSet expected $650.4 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Forum Energy Metals Seeking Up To $1 Million in a Private Placement of Share Units
Forum Energy Metals Seeking Up To $1 Million in a Private Placement of Share Units
Jun 3, 2024
12:56 PM EDT, 06/03/2024 (MT Newswires) -- Forum Energy Metals ( FDCFF ) said Monday it is seeking up to $1 million from a private placement of share units. The company is offering 7.41-million units in the financing, with each priced at $0.135 and made up of a share and one half of a two-year warrant to buy a second...
BRIEF-Skydance To Offer $23 A Share For Paramount Voting Stock - Bloomberg News
BRIEF-Skydance To Offer $23 A Share For Paramount Voting Stock - Bloomberg News
Jun 3, 2024
June 3 (Reuters) - * SKYDANCE TO OFFER $23 A SHARE FOR PARAMOUNT VOTING STOCK - BLOOMBERG NEWS Source text : [ID: https://bit.ly/3KxjYi8 ] Further company coverage: ...
Why Affimed Shares Are Soaring
Why Affimed Shares Are Soaring
Jun 3, 2024
Affimed N.V. ( AFMD ) shares are trading higher Monday after the company announced additional follow-up data from the on-going AFM24-102 study in non-small cell lung cancer (NSCLC). The Details: Affimed ( AFMD ) said in 17 EGFR wild-type (EGFRwt) non-small cell lung cancer (NSCLC) patients who failed chemotherapy and PD-1/PD-L1, AFM24 plus atezolizumab achieved four objective responses, three of...
JetBlue Airways Sees Smaller Second-Quarter Revenue Decline Than Previously Expected
JetBlue Airways Sees Smaller Second-Quarter Revenue Decline Than Previously Expected
Jun 3, 2024
01:00 PM EDT, 06/03/2024 (MT Newswires) -- JetBlue Airways ( JBLU ) updated its second-quarter guidance on Monday to now reflect a smaller year-over-year revenue decline at the midpoint than previously projected, as well as lower expenses. The carrier is expecting revenue to decline by 6.5% to 9.5% on an annual basis in the quarter ending June 30. That compares...
Copyright 2023-2026 - www.financetom.com All Rights Reserved